• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Aegerion Pharmaceuticals, Inc. (AEGR)

    -NasdaqGS
    17.66 Down 0.10(0.56%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2015Mar 31, 2015Dec 31, 2014Sep 30, 2014
    Total Revenue 64,197   59,384   51,712   43,674  
    Cost of Revenue13,997  11,838  3,765  3,783  
    Gross Profit 50,200   47,546   47,947   39,891  
    Operating Expenses
    Research Development12,471  9,798  10,701  10,438  
    Selling General and Administrative42,672  46,928  37,170  31,436  
    Non Recurring -   -  1  4  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (4,943) (9,180) 75   (1,987)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,116  485  (1,198)(511)
    Earnings Before Interest And Taxes(3,827)(8,695)(1,123)(2,498)
    Interest Expense7,069  6,931  6,621  3,175  
    Income Before Tax(10,896)(15,626)(7,744)(5,673)
    Income Tax Expense254  199  372  198  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(11,150)(15,825)(8,116)(5,871)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (11,150) (15,825) (8,116) (5,871)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (11,150) (15,825) (8,116) (5,871)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.